Explore rare diseases studied in clinical trials – page 4
Top 10 most studied rare diseases
Rare diseases with the highest number of active trials right now.
Colours show each disease's body system – lighter shades rank lower.
- Blood and lymphatic system disorders58%
- Gastrointestinal disorders14%
- Neoplasms benign, malignant and unspecified11%
- Hepatobiliary disorders10%
- Immune system disorders7%
No. 1 most studied
Plasma cell myeloma
- recruiting now
- 46
- countries
- 25
- open to children
- 0
- substances tested
- 141
Shares are of these ten diseases' active trials together.
All rare diseases
Browse every rare disease currently studied across European trials.
648 rare diseases
Malignant peritoneal neoplasm
14 clinical trialsMalignant peritoneal neoplasm
- 17 countries
- Substances:AprepitantAzenosertib+25 more
Polycythaemia vera
14 clinical trialsPolycythaemia vera
- 16 countries
- Substances:BomedemstatCarbasalate Calcium+9 more
Chronic graft versus host disease
13 clinical trialsChronic graft versus host disease
- 24 countries
- Substances:AxatilimabBelumosudil+11 more
Congenital cystic kidney disease
13 clinical trialsCongenital cystic kidney disease
- 10 countries
- Substances:ABBV-CLS-628Amiloride+5 more
Factor IX deficiency
13 clinical trialsFactor IX deficiency
- 23 countries
- Substances:ConcizumabEfmoroctocog Alfa+7 more
Metastatic renal cell carcinoma
13 clinical trialsMetastatic renal cell carcinoma
- 16 countries
- Substances:AxitinibCabozantinib+11 more
Osteosarcoma
13 clinical trialsOsteosarcoma
- 13 countries
- Substances:AnakinraCabozantinib+9 more
Sickle cell anaemia
13 clinical trialsSickle cell anaemia
- 7 countries
- Substances:BusulfanCrizanlizumab+8 more
Adrenogenital syndrome
12 clinical trialsAdrenogenital syndrome
- 19 countries
- Substances:AtumelnantCrinecerfont+2 more
Alpha-1 antitrypsin deficiency
12 clinical trialsAlpha-1 antitrypsin deficiency
- 14 countries
- Substances:ALPHA-1-ANTITRYPSINEfdoralprin alfa+4 more
Cholangitis sclerosing
12 clinical trials- 16 countries
- Substances:A3907Bezafibrate+5 more
Glioblastoma multiforme
12 clinical trialsGlioblastoma multiforme
- 13 countries
- Substances:AtezolizumabGemcitabine+12 more
Myotonic dystrophy
12 clinical trialsOsteochondrodysplasia
12 clinical trialsOsteochondrodysplasia
- 15 countries
- Substances:InfigratinibLonapegsomatropin+2 more
Waldenstrom's macroglobulinaemia
12 clinical trialsWaldenstrom's macroglobulinaemia
- 14 countries
- Substances:BortezomibCarfilzomib+18 more
Central nervous system lymphoma
11 clinical trialsCentral nervous system lymphoma
- 12 countries
- Substances:Calcium FolinateCyclophosphamide+15 more
Chronic myelomonocytic leukaemia
11 clinical trialsChronic myelomonocytic leukaemia
- 14 countries
- Substances:AllopurinolAzacitidine+9 more
Fabry's disease
11 clinical trialsFabry's disease
- 15 countries
- Substances:Agalsidase alfaAgalsidase beta+7 more
Graft versus host disease
11 clinical trialsGraft versus host disease
- 14 countries
- Substances:ALPHA-1-ANTITRYPSINIbrutinib+6 more
Hypoparathyroidism
11 clinical trialsHypoparathyroidism
- 14 countries
- Substances:AlfacalcidolCalcitriol+5 more
Idiopathic inflammatory myopathy
11 clinical trialsIdiopathic inflammatory myopathy
- 19 countries
- Substances:AldesleukinAzathioprine+18 more
Neuroendocrine carcinoma
11 clinical trialsNeuroendocrine carcinoma
- 15 countries
- Substances:AtezolizumabAvelumab+18 more
Pleural mesothelioma malignant
11 clinical trialsPleural mesothelioma malignant
- 7 countries
- Substances:AlrefimotideAtezolizumab+14 more
About rare diseases in clinical trials
A disease is called rare in the EU when it affects fewer than 5 in 10 000 people. Individually uncommon, together they affect millions – and most still have no approved treatment.
Because the number of patients is small, trials in rare diseases often recruit across several countries at once. That is why a trial listed here may be worth looking at even when it runs nowhere near you.
